[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Antinuclear Antibody Test Market Size, Share, and Analysis, By Product (Reagents & Assay Kits, Systems, Software, and Services), By Technique (ELISA, Immunofluorescence Assay, and Multiplex Assay), By Application (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Scleroderma, and Others), By End-use (Hospitals, Clinical Laboratories, Physician Office Laboratories, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034

May 2024 | 439 pages | ID: AEBEA44DAD92EN
Fatpos Global

US$ 5,150.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Antinuclear Antibody Test Market Size, Share, and Analysis, By Product (Reagents & Assay Kits, Systems, Software, and Services), By Technique (ELISA, Immunofluorescence Assay, and Multiplex Assay), By Application (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Scleroderma, and Others), By End-use (Hospitals, Clinical Laboratories, Physician Office Laboratories, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034

PRODUCT OVERVIEW

Antinuclear Antibody Test Market is anticipated t%li%exhibit a Compound Annual Growth Rate (CAGR) of 11.3% during the forecast span from 2024 t%li%2034. In 2023, the market size was assessed at USD 2 billion and is projected t%li%reach USD 6.6 billion by the completion of 2034.

Antinuclear Antibody (ANA) Test is a diagnostic procedure which is designed t%li%identify antibodies targeting the body's cell nuclei and reveal potential autoimmune disorders such as lupus or rheumatoid arthritis. This examination involves analyzing a patient's blood for antinuclear antibodies, which bind t%li%various components within cell nuclei. A positive result indicates an abnormal immune response, which encourages further investigation int%li%specific autoimmune conditions. Additionally, despite its sensitivity, the ANA Test lacks specificity for a particular disease, and requires additional tests and clinical evaluation for precise diagnosis. Furthermore, the ANA Test, which is widely used by rheumatologists, helps t%li%diagnose autoimmune illnesses early on, thereby allowing for timely medical intervention. This screening is significant for identifying underlying health concerns and developing suitable treatment options.

MARKET HIGHLIGHTS

Antinuclear Antibody Test Market is projected t%li%reach USD 6.6 billion over the forecast period, owing t%li%the increasing prevalence of autoimmune diseases. The expansion of the market is attributed t%li%several factors such as heightened awareness, along with early disease detection initiatives and improvements in healthcare infrastructure. Moreover, the rising incidence of autoimmune disorders such as lupus and rheumatoid arthritis, combined with the aging population, is responsible for the growing demand of precise diagnostic tools such as the ANA Test. Additionally, major industry players are actively investing in research & development t%li%introduce innovative products, which further strengthens their market presence. Therefore, the market is expected t%li%experience sustained growth, which highlights the crucial role of antinuclear antibody test in addressing the diagnostic needs associated with autoimmune disorders on a global scale.

Antinuclear Antibody Test Market Segments:
  • By Product
  • Reagents & Assay Kits
  • Systems
  • Software
  • Services
  • By Technique
  • ELISA
  • Immunofluorescence Assay
  • Multiplex Assay
  • By Application
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Scleroderma
  • Others
  • By End-Use
  • Hospitals
  • Clinical Laboratories
  • Physician Office Laboratories
  • Others
MARKET DYNAMICS

Growth Drivers

Increased Prevalence of Autoimmune Diseases Will Create Growth Opportunities

Technological Improvements in Diagnostics Will Lead t%li%Market Expansion

Restraint

Lack of Specificity in Diagnosis can Prevent Industry Growth

Key Players
    • Therm%li%Fisher Scientific
  • Bio-Rad Laboratories
  • Quest Diagnostics
  • Antibodies Incorporated
  • AESKU Group
  • Erba Mannheim
  • Roche Diagnostics
  • EUROIMMUN
  • Inova Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Beckman Coulter
    • Immun%li%Concepts
  • Zeus Scientific
  • Aesku.Diagnostics
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Laboratory Temperature Control Units Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Reasons t%li%Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
      • Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
    • The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
    • Provides insight int%li%the market through Value Chain
    • Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
  • 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY

1.1.Regional Market Share
1.2. Business Trends
1.3.Antinuclear Antibody Test Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot

2. RESEARCH METHODOLOGY

2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
  2.5.1. Paid Sources
  2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation

3. MARKET CHARACTERISTICS

3.1. Market Definition
3.2.Antinuclear Antibody Test Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data

4. ANTINUCLEAR ANTIBODY TEST MARKET – INDUSTRY INSIGHTS

4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability

5. MACROECONOMIC INDICATORS

6. RECENT DEVELOPMENTS

7.MARKET DYNAMICS

7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends

8. RISK ANALYSIS

9. MARKET ANALYSIS

9.1. Porters Five Forces
9.2.PEST Analysis
  9.2.1. Political
  9.2.2.Economic
  9.2.3.Social
  9.2.4.Technological

10. ANTINUCLEAR ANTIBODY TEST MARKET

10.1.Overview
10.2. Historical Analysis (2019-2022)
  10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast

11.ANTINUCLEAR ANTIBODY TEST MARKET SIZE & FORECAST 2024A-2034F

11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
  11.3.1.By Product
    11.3.1.1. Reagents and Assay Kits
      11.3.1.1.1. By Value (USD Million) 2024-2034F
      11.3.1.1.2.Market Share (%) 2024-2034F
      11.3.1.1.3.Y-o-Y Growth (%) 2024-2034F
    11.3.1.2.Systems
      11.3.1.2.1.By Value (USD Million) 2024-2034F
      11.3.1.2.2. Market Share (%) 2024-2034F
      11.3.1.2.3. Y-o-Y Growth (%) 2024-2034F
    11.3.1.3.Software
      11.3.1.3.1.By Value (USD Million) 2024-2034F
      11.3.1.3.2. Market Share (%) 2024-2034F
      11.3.1.3.3. Y-o-Y Growth (%) 2024-2034F
    11.3.1.4.Services
      11.3.1.4.1.By Value (USD Million) 2024-2034F
      11.3.1.4.2. Market Share (%) 2024-2034F
      11.3.1.4.3. Y-o-Y Growth (%) 2024-2034F
  11.3.2. By Technique
    11.3.2.1.Elisa
      11.3.2.1.1.By Value (USD Million) 2024-2034F
      11.3.2.1.2. Market Share (%) 2024-2034F
      11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
    11.3.2.2. Immunofluorescence Assay
      11.3.2.2.1. By Value (USD Million) 2024-2034F
      11.3.2.2.2.Market Share (%) 2024-2034F
      11.3.2.2.3.Y-o-Y Growth (%) 2024-2034F
    11.3.2.3. Multiplex Assay
      11.3.2.3.1. By Value (USD Million) 2024-2034F
      11.3.2.3.2.Market Share (%) 2024-2034F
      11.3.2.3.3.Y-o-Y Growth (%) 2024-2034F
  11.3.3. By Application
    11.3.3.1.Rheumatoid Arthritis
      11.3.3.1.1.By Value (USD Million) 2024-2034F
      11.3.3.1.2. Market Share (%) 2024-2034F
      11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
    11.3.3.2. Systemic Lupus Erythematosus
      11.3.3.2.1. By Value (USD Million) 2024-2034F
      11.3.3.2.2.Market Share (%) 2024-2034F
      11.3.3.2.3.Y-o-Y Growth (%) 2024-2034F
    11.3.3.3. Scleroderma
      11.3.3.3.1. By Value (USD Million) 2024-2034F
      11.3.3.3.2.Market Share (%) 2024-2034F
      11.3.3.3.3.Y-o-Y Growth (%) 2024-2034F
    11.3.3.4. Others
      11.3.3.4.1. By Value (USD Million) 2024-2034F
      11.3.3.4.2. Market Share (%) 2024-2034F
      11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F
  11.3.4. By End-Use
    11.3.4.1.Hospitals
      11.3.4.1.1.By Value (USD Million) 2024-2034F
      11.3.4.1.2. Market Share (%) 2024-2034F
      11.3.4.1.3. Y-o-Y Growth (%) 2024-2034F
    11.3.4.2. Clinical Laboratories
      11.3.4.2.1. By Value (USD Million) 2024-2034F
      11.3.4.2.2.Market Share (%) 2024-2034F
      11.3.4.2.3. Y-o-Y Growth (%) 2024-2034F
    11.3.4.3. Physician Office Laboratories
      11.3.4.3.1. By Value (USD Million) 2024-2034F
      11.3.4.3.2. Market Share (%) 2024-2034F
      11.3.4.3.3. Y-o-Y Growth (%) 2024-2034F
    11.3.4.4. Others
      11.3.4.4.1.By Value (USD Million) 2024-2034F
      11.3.4.4.2. Market Share (%) 2024-2034F
      11.3.4.4.3. Y-o-Y Growth (%) 2024-2034F

12. NORTH AMERICA ANTINUCLEAR ANTIBODY TEST MARKET SIZE & FORECAST 2024A-2034F

12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
  12.3.1. By Product
  12.3.2.By Technique
  12.3.3.By Application
  12.3.4.By End-Use
12.4. Country
  12.4.1. United States
  12.4.2.Canada

13. EUROPE ANTINUCLEAR ANTIBODY TEST MARKET SIZE & FORECAST 2024A-2034F

13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
  13.3.1. By Product
  13.3.2.By Technique
  13.3.3.By Application
  13.3.4.By End-Use
13.4. Country
  13.4.1.Germany
  13.4.2.United Kingdom
  13.4.3.France
  13.4.4. Italy
  13.4.5.Spain
  13.4.6.Russia
  13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)

14. ASIA-PACIFIC ANTINUCLEAR ANTIBODY TEST MARKET SIZE & FORECAST 2024A-2034F

14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
  14.3.1. By Product
  14.3.2.By Technique
  14.3.3.By Application
  14.3.4. By End-Use
14.4. Country
  14.4.1. India
  14.4.2.China
  14.4.3. South Korea
  14.4.4. Japan
  14.4.5. Rest of APAC

15. MIDDLE EAST AND AFRICA ANTINUCLEAR ANTIBODY TEST MARKET SIZE & FORECAST 2024A-2034F

15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
  15.3.1. By Product
  15.3.2.By Technique
  15.3.3.By Application
  15.3.4.By End-Use
15.4. Country
  15.4.1. Israel
  15.4.2.GCC
  15.4.3.North Africa
  15.4.4. South Africa
  15.4.5.Rest of Middle East and Africa

16. LATIN AMERICA ANTINUCLEAR ANTIBODY TEST MARKET SIZE & FORECAST 2024A-2034F

16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
  16.3.1. By Product
  16.3.2.By Technique
  16.3.3.By Application
  16.3.4.By End-Use
16.4. Country
  16.4.1. Mexico
  16.4.2.Brazil
  16.4.3.Rest of Latin America

17. COMPETITIVE LANDSCAPE

17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders

18. COMPANY PROFILES

18.1.Thermo Fisher Scientific
  18.1.1.Company Overview
  18.1.2.Financial Overview
  18.1.3.Key Product; Analysis
  18.1.4.Company Assessment
    18.1.4.1.Product Portfolio
    18.1.4.2. Key Clients
    18.1.4.3. Market Share
    18.1.4.4. Recent News & Development (Last 3 Yrs.)
    18.1.4.5. Executive Team
18.2.Siemens Healthineers
18.3.Roche Diagnostics
18.4. Bio-Rad Laboratories
18.5.Abbott Laboratories
18.6.Quest Diagnostics
18.7.Beckman Coulter
18.8. EUROIMMUN
18.9.Inova Diagnostics
18.10.Antibodies Incorporated
18.11. AESKU Group
18.12. Erba Mannheim
18.13. Immuno Concepts
18.14.Zeus Scientific
18.15. Aesku.Diagnostics
18.16.Other Prominent Players

19. APPENDIX

20.CONSULTANT RECOMMENDATION



More Publications